NSE shareholding pattern
JB Chemicals & Pharmaceuticals Limited shareholding pattern
As of the Mar 2026 shareholding pattern (quarter ended 2026-03-31), promoters held 48.8%, FIIs 16.33%, and DIIs 21.38% of JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM). In the Dec 2025 pattern the same figures were promoter 47.55%, FII 14.88% and DII 23.35%. Promoter holding changed between the two filings, so the percentages moved for every category and the difference is not a count of shares bought or sold. The table below shows how promoter, FII, DII and public holding has moved quarter by quarter, taken from the NSE shareholding pattern.
Smart Money Report, Q2 FY27: shareholding patterns as they are filed, 1 Oct 2026 to 21 Oct 2026
Definition
A shareholding pattern is the quarterly breakdown of who owns a listed company, split across promoters, foreign institutional investors (FII), domestic institutional investors (DII), and the public. Indian companies file it every quarter under SEBI listing rules. Source: NSE shareholding pattern.
JB Chemicals & Pharmaceuticals Limited shareholding by quarter
| Quarter | Promoter % | FII % | DII % | Public % | Filed |
|---|---|---|---|---|---|
| Mar 2026 | 48.8 | 16.33 | 21.38 | 13.49 | 2026-03-31 |
| Jan 2026 | 48.78 | 14.55 | 22.71 | 13.96 | 2026-01-23 |
| Dec 2025 | 47.55 | 14.88 | 23.35 | 14.22 | 2025-12-31 |
| Sep 2025 | 47.56 | 15.31 | 22.83 | 14.3 | 2025-09-30 |
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
- Smart money moves this filing week (insider trades, bulk deals and stake disclosures from the last 7 days)
- All NSE shareholding patterns (browse every company by name)
- What is a 13F filing? (how the US equivalent disclosure works)
- FII and DII activity, sourced and dated
- Today's NSE and BSE bulk and block deals
- Shareholding patterns for other companies in the same industry: Jubilant Pharmova Limited, Laurus Labs Limited, Lupin Limited, Mankind Pharma Limited, Marksans Pharma Limited, Natco Pharma Limited, Neuland Laboratories Limited, Onesource Specialty Pharma Limited
- When smart money's filings overlap (multi-entity disclosure overlap, explained)
Frequently asked questions
What is the promoter holding in JB Chemicals & Pharmaceuticals Limited?
As of the Mar 2026 shareholding pattern, promoters held 48.8% of JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM). Figures are taken from the NSE shareholding pattern filing dated 2026-03-31 and may change each quarter. Not investment advice.
What is the FII holding in JB Chemicals & Pharmaceuticals Limited?
Foreign institutional investors held 16.33% of JB Chemicals & Pharmaceuticals Limited as of the Mar 2026 pattern, versus 14.88% in the Dec 2025 pattern. Promoter holding changed between the two filings, so both are levels rather than a change in holding. Source: NSE shareholding pattern, quarter ended 2026-03-31. Not investment advice.
How often is the shareholding pattern updated?
Listed Indian companies disclose their shareholding pattern every quarter under SEBI's listing rules. Flock re-stamps each page when a new quarterly pattern is filed, so the freshness chip reflects the true age of the latest data.
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.